Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-25 @ 9:25 PM
Study NCT ID:
NCT00280956
Status:
COMPLETED
Last Update Posted:
2016-06-16
First Post:
2006-01-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-07
Start Date Type:
None
Primary Completion Date:
2004-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-09
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-21
First Submit QC Date:
None
Study First Post Date:
2006-01-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-14
Last Update Post Date:
2016-06-16
Last Update Post Date Type:
ESTIMATED